Mexate (250 Mg) contains following Salts:-
Methotrexate - Drug Information
Typical usage: :Adjunct in the short term symtomastic treatment of muscle spasm.
Probable Side Effects: :Ulceration of the mouth and GI disturbances, bone marrow depression, hepatotoxicity, renal failure, skin reactions, alopecia, megaloblastic anaemia, osteoporosis, precipitation of diabetes, arthralgias, necrosis of soft tissue and bone, anaphylaxis, impaired fertility. Potentially Fatal: Pulmonary reactions (e.g. interstitial lung disease); neurotoxicity (e.g. leukoencephalopathy, paresis, demyelination) with intrathecal use.
Drug Interaction: Decreased effectiveness with folic acid and its derivatives. Potentially Fatal: Increased toxicity with NSAIDs and salicylates; probenecid; some penicillins; aminoglycosides neomycin and paromomycin; sulfonamides such as sulfafurazole and sulfamethoxazole; co-trimoxazole or trimethoprim; nephrotoxic agents (e.g. cisplatin); ciclosporin; etretinate. Synergistic enhancement of effects with fluorouracil. Increased bioavailability of mercaptopurine. Reduces serum-valproate concentrations. Reduced serum concentrations with colestyramine. Increased serum concentrations with omeprazole.
Mechanism of Action: Methotrexate is a folic acid antagonist that inhibits DNA synthesis. It irreversibly binds to dihydrofolate reductase, inhibiting the formation of reduced folates, and thymidylate synthetase, resulting in inhibition of purine and thymidylic acid synthesis.
Pregnancy Impact: Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
Impact During Lactation: Studies in breastfeeding mothers have demonstrated that there is significant and documented risk to the infant based on human experience, or it is a medication that has a high risk of causing significant damage to an infant. The risk of using the drug in breastfeeding women clearly outweighs any possible benefit from breastfeeding. The drug is contraindicated in women who are breastfeeding an infant.
Price of Mexate (250 Mg) : Rs.240.00
|Dispatches by||Next Day|
|Composition||Methotrexate 25 mg|
|Pack Size||1 Unit in Vial|
Use spaces to separate tags. Use single quotes (') for phrases.
FAQ on Mexate (250 Mg)
There are no product questions yet.
We guarantee to ship your order next day after order has been submitted
Please contacts us and our customer service team will answer all your questions
If you are not satisfied with your order - send it back within 14 days after day of purchase!
Substitutes of Mexate (250 Mg)
Rs.1.00Cyper Drugs & Pharma
Rs.1.00Orchid Chemicals & Pharma
Rs.1.00Low Cost Standard Therapeutics (Locost)
- Mail Today
- Bio Spectrum
- The Financial Chronicle
- Business Standard
- News Informer
- Business Standard
- News Prelease
- Biznews Index
- 15 Minute News
- Biz Radar
- VNI India
- Khari News
- Hunt News
- Express Pharma
- Silicon India
- The Hindu
- Your Story
- Stratos Invest
- EPL India
- Hindustan Times
- The Times of India